April 16, 2018 / 12:05 PM / 8 months ago

BRIEF-Syros Announces New Preclinical Data On SY-1365 Showing Potent Anti-Tumor Activity In Multiple Models Of Heavily Pretreated Ovarian Cancer

April 16 (Reuters) - Syros Pharmaceuticals Inc:

* SYROS ANNOUNCES NEW PRECLINICAL DATA ON SY-1365 SHOWING POTENT ANTI-TUMOR ACTIVITY IN MULTIPLE MODELS OF HEAVILY PRETREATED OVARIAN CANCER

* SYROS PHARMACEUTICALS INC - ON TRACK TO REPORT DATA FROM DOSE ESCALATION PORTION OF PHASE 1 TRIAL IN Q4 OF 2018

* SYROS PHARMACEUTICALS INC - EXPECT TO OPEN EXPANSION COHORTS IN PHASE 1 TRIAL IN MID-2018 Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below